骨肿瘤患者的血沉与C—反应蛋白的临床意义
被引量：1
摘要
血沉是对骨科医生最有帮助的化验检查之一，Ｃ—反应蛋白也日益引起骨科医生的重视［１］，但骨肿瘤患者手术前后的血沉与Ｃ—反应蛋白变化尚缺乏全面的临床评价。自１９９６年１月至１９９７年３月，我科对骨肿瘤患者手术前后的血沉及Ｃ—反应蛋白进行前瞻性观察，初步报...
出处
《中国矫形外科杂志》
CAS
CSCD
1999年第1期52-52,共1页
Orthopedic Journal of China
同被引文献16
-
1何仁荣,刘金文.骨肿瘤患者血液流变学指标的临床分析[J].亚太传统医药,2007,3(2):60-61. 被引量：1
-
2Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection ControlPractices Advisory Committee[J]. Infect Control Hosp Epidemiol, 1999,20(4):250-278.
-
3Braga M, Vignali A, Radaelli G, et al. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer[J]. Eur J Surg, 1992,158(10):531-536.
-
4National Nosocomial Infections Surveillance System. National nosocomial infections surveillance(NNIS) system report, data summary from January 1992 through June 2004, issued October 2004[J]. Am J Infect Control, 2004,32(8):470-485.
-
5Freitas PF, Campos ML, Cipriano ZM. Suitability of the hospital infection National surveillance system (NNISS) risk index for the prediction of the incidence of surgical site infection at a university hospital in florianopolis, South Brazil[J]. Rev Assoc Med Bras, 2001,46(4):359-362.
-
6Haridas M, Malangoni MA. Predictive factors for surgical site infection in general surgery[J]. Surgery, 2008,144(4):496-503. DOI: 10.1016/j.surg.2008.06.001.
-
7Van Kasteren ME, Mannin J, Ott A, et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor[J]. Clin Infect Dis, 2007,44(7):921-927.
-
8de Boer AS, Mintjes-de Groot AJ, Severijnen AJ, et al. Risk assessment for surgical-site infections in orthopedic patients[J]. Infect Control Hosp Epidemiol, 1999,20(6):402-407.
-
9Morris CD, Sepkowitz K, Fonshell C, et al. Prospective identification of risk factors for wound infection after lower extremity oncologic surgery[J]. Ann Surg Oncol, 2003,10(7):778-782.
-
10Mcalister F, Clark HD, Wells PS, et al. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies[J]. Br J Surg, 1998,85(2):171-178.
-
1傅义明.血沉在临床应用中的几个问题[J].中国乡村医生,1995,10(11):43-44. 被引量：1
-
2崔智勇.用食管癌根治术联合放疗治疗食管癌的效果分析[J].当代医药论丛,2015,13(7):30-31. 被引量：2
-
3李志强,李立文,李长江.恶性骨肿瘤20例治疗体会[J].山东医药,2007,47(29):43-43.
-
4雷咏震,刘媛,安立.反应停联合化疗治疗多发性骨髓瘤6例观察[J].东南大学学报（医学版）,2003,22(3):184-185.
-
5陈虹.血沉检测在肿瘤诊治中的应用价值[J].中国肿瘤临床与康复,2000,7(4):40-40. 被引量：1
-
6刘勇安.101例肺癌患者C-反应蛋白及纤维蛋白原的结果分析[J].数理医药学杂志,2016,29(5):683-684.
-
7任朝凤,李梅华,杨丽芬.血清中多项联合检测在肺癌诊断中的临床意义[J].昆明医科大学学报,2013,34(12):130-131. 被引量：3
-
8谢丹萍,邱懿,李玉闽.血清C—反应蛋白测定在白血病合并感染中的诊断价值探讨[J].西藏医药,2001,22(2):58-59.
-
9张汀荣,曾洁,赵韬,顾小伟.三维适形放疗联合复方苦参注射液治疗转移性骨肿瘤疗效观察[J].山东医药,2011,51(9):90-91. 被引量：7
-
10张学利,朱素范.23例老年多发性骨髓瘤临床分析[J].吉林医学院学报,1997,17(3):61-62.
